Skip to main content

Table 1 Characteristics of eligible subjects

From: Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling

 

Participated (n = 30)

Declined (n = 20)

p value

Age (years)

15.2 ± 2.7

14.7 ± 2.4

0.17

Male (%)

50

70

0.72

Anthracycline dose (mg/m2)

197.2 ± 84.3

200.2 ± 83.0

0.92

Time from chemo (years)

7.6 ± 4.5

8.3 ± 5.0

0.90

Chest irradiation (%)

17%

25%

0.72